Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations

Core Insights - The company delivered FY2025 adjusted EPS at the midpoint of the updated outlook range, indicating stable performance despite market challenges [1] - The '3-S Plan' is advancing with Perrigo Store Brand OTC and key brands gaining market share in 2025, despite soft category consumption [1] - A new operational enhancement program is being launched, expected to deliver pre-tax annualized savings of $80 million to $100 million [1] - The company will transition to new reporting segments beginning Q1 2026, aligning with its commercial operating model [1] - FY2026 'All In' outlook has been issued, along with the introduction of FY2026 'CORE' outlook, which excludes infant formula and previously announced divestitures [1] Financial Performance - For Q4 2025, net sales were reported at $1.11 billion, reflecting a year-over-year decline of 2.5% [1] - Favorable foreign exchange contributed positively by 2.3%, but this was more than offset by organic net sales decline of 4.5% and the impact of divestitures and exited products, which accounted for a 0.4% decrease [1]